Tailored Thienopyridine therapy: no urgency for CYP2C19 genotyping
Contributors
Fontana, PierrePublished in
Journal of the American Heart Association. Cardiovascular and cerebrovascular disease, vol. 2, no. 2, e000131Publication date
2013Abstract
UNIGE affiliation entities
UNIGE research groups
Citation (ISO format)
FONTANA, Pierre et al. Tailored Thienopyridine therapy: no urgency for CYP2C19 genotyping. In: Journal of the American Heart Association. Cardiovascular and cerebrovascular disease, 2013, vol. 2, n° 2, p. e000131. doi: 10.1161/JAHA.112.000131
Main files (1)
Article (Published version)
Identifiers
- PID : unige:29632
- DOI : 10.1161/JAHA.112.000131
- PMID : 23537811
